Serum potassium influencing interacting drugs: risk-modifying strategies also needed at discontinuation

E.V. Uijtendaal, J.E.F. Zwart-van Rijkom, W.W. van Solinge, A.C.G. Egberts

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{eabaa29c40f944a6894192eee79df797,

title = "Serum potassium influencing interacting drugs: risk-modifying strategies also needed at discontinuation",

author = "E.V. Uijtendaal and {Zwart-van Rijkom}, J.E.F. and {van Solinge}, W.W. and A.C.G. Egberts",

year = "2012",

language = "Undefined/Unknown",

volume = "46",

pages = "176--182",

journal = "Annals of Pharmacotherapy",

issn = "1060-0280",

publisher = "SAGE Publications Inc.",

number = "2",

}